Spanish Menopause Society position statement: Use of denosumab in postmenopausal women

被引：0
|
作者：
Canoa, Antonio [1 ]
Manuel Silvan, Jose [2 ]
Estevez, Antonio [3 ]
Baro, Francesc [4 ]
Villero, Jose [5 ]
Quereda, Francisco [6 ]
Ferrer, Javier [7 ]
Mendoza, Nicolas [8 ]
Sanchez-Borrego, Rafael [9 ]
机构：
[1] Univ Valencia, Hosp Univ Dr Peset, Valencia, Spain
[2] Univ Seville, Hosp Univ Virgen Bocio, Seville, Spain
[3] Hosp Univ Valme, Seville, Spain
[4] Univ Barcelone, Hosp Vall Hebron, Barcelona, Spain
[5] Hosp Reina Sofia, Cordoba, Spain
[6] Univ Miguel Hernandez, Hosp Univ San Juan Alicante, Alicante, Spain
[7] Univ Oviedo, Hosp Univ Cent Asturias, Oviedo, Spain
[8] Univ Granada, Dept Obstet & Gynecol, Granada, Spain
[9] Clin Diatros, Barcelona, Spain
来源：
MATURITAS | 2014年 / 79卷 / 01期
关键词：
Denosumab; Postmenopausal osteoporosis; Breast cancer; BONE-MINERAL DENSITY; PHASE-2; CLINICAL-TRIAL; COST-EFFECTIVENESS; ZOLEDRONIC ACID; BREAST-CANCER; ECONOMIC-EVALUATION; OSTEOPOROTIC WOMEN; FREEDOM EXTENSION; PROSTATE-CANCER; METASTASES;
D O I：
10.1016/j.maturitas.2014.06.011
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Denosumab is a new drug developed for the treatment of osteoporosis. Moreover, increasing evidences link denosumab with benefits in cancer, an area of interest for those in charge of the postmenopausal health. Denosumab has shown efficacy in the control of bone loss associated with hypogonadic states created by chemotherapy in breast and other cancers. Moreover, some studies reveal efficacy in reducing the progression of metastases. A panel of experts from the Spanish Menopause Society has met to develop usage recommendations based on the best available evidence. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：117 / 121
页数：5
相关论文
共 50 条
  • [31] The 2022 hormone therapy position statement of The North American Menopause Society
    Faubion, Stephanie S.
    Crandall, Carolyn J.
    Davis, Lori
    El Khoudary, Samar R.
    Hodis, Howard N.
    Lobo, Roger A.
    Maki, Pauline M.
    Manson, JoAnn E.
    Pinkerton, JoAnn V.
    Santoro, Nanette F.
    Shifren, Jan L.
    Shufelt, Chrisandra L.
    Thurston, Rebecca C.
    Wolfman, Wendy
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (07): : 767 - 794
  • [32] Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society
    Santoro, NF
    Clarkson, TB
    Freedman, RR
    Fugh-Berman, AJ
    Loprinzi, CL
    Reame, NK
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (01): : 11 - 33
  • [33] The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement
    Rees, Margaret
    Abernethy, Kathy
    Bachmann, Gloria
    Bretz, Silvia
    Ceausu, Iuliana
    Durmusoglu, Fatih
    Erkkola, Risto
    Fistonic, Ivan
    Gambacciani, Marco
    Geukes, Marije
    Goulis, Dimitrios G.
    Griffiths, Amanda
    Hamoda, Haitham
    Hardy, Claire
    Hartley, Caiomhe
    Hirschberg, Angelica Linden
    Kydd, Angela
    Marshall, Skye
    Meczekalski, Blazej
    Mendoza, Nicolas
    Mueck, Alfred
    Persand, Emma
    Riach, Kathleen
    Smetnik, Antonina
    Stute, Petra
    van Trotsenburg, Mick
    Yuksel, Nese
    Weiss, Rachel
    Lambrinoudaki, Irene
    MATURITAS, 2022, 158 : 70 - 77
  • [34] Highlights From the 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society
    Faubion, Stephanie S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1452 - 1452
  • [35] Global consensus recommendations on menopause in the workplace: A European Menopause and Andropause Society (EMAS) position statement
    Rees, Margaret
    Bitzer, Johannes
    Cano, Antonio
    Ceausu, Iuliana
    Chedraui, Peter
    Durmusoglu, Fatih
    Erkkola, Risto
    Geukes, Marije
    Godfrey, Alan
    Goulis, Dimitrios G.
    Griffiths, Amanda
    Hardy, Claire
    Hickey, Martha
    Hirschberg, Angelica Linden
    Hunter, Myra
    Kiesel, Ludwig
    Jack, Gavin
    Lopes, Patrice
    Mishra, Gita
    Oosterhof, Henk
    Pines, Amos
    Riach, Kathleen
    Shufelt, Chrisandra
    van Trotsenburg, Mick
    Weiss, Rachel
    Lambrinoudaki, Irene
    MATURITAS, 2021, 151 : 55 - 62
  • [36] Joint Position Statement of the Polish Cardiologic Society, the Polish Gynaecological Society and the Polish Menopause and Andropause Society on the effect of postmenopausal hormone replacement therapy on the cardiovascular system
    Kornacewicz-Jach, Zdzislawa
    Czarnecka, Danuta
    Rynkiewicz, Andrzej
    Kotarski, Jan
    Paszkowski, Tomasz
    Pertynski, Tomasz
    Debski, Romuald
    Wielgos, Miroslaw
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (05) : 261 - 266
  • [37] CONSENSUS STATEMENT ON PROGESTIN USE IN POSTMENOPAUSAL WOMEN
    UTIAN, WH
    MATURITAS, 1989, 11 (03) : 175 - 177
  • [38] Guidelines for the hormone treatment of women in the menopausal transition and beyond -: Position statement by the executive committee of the international menopause society
    Naftolin, F
    Schneider, HPG
    Sturdee, DW
    Birkhäuser, M
    Brincat, MP
    Gambacciani, M
    Genazzani, AR
    Limpaphayom, KK
    O'Neill, S
    Palacios, S
    Pines, A
    Siseles, N
    Tan, D
    CLIMACTERIC, 2004, 7 (01) : 8 - 11
  • [39] EMAS position statement: Managing the menopause in women with a past history of endometriosis
    Moen, Mette H.
    Rees, Margaret
    Brincat, Marc
    Erel, Tamer
    Gambacciani, Marco
    Lambrinoudaki, Irene
    Schenck-Gustafsson, Karin
    Tremollieres, Florence
    Vujovic, Svetlana
    Rozenberg, Serge
    MATURITAS, 2010, 67 (01) : 94 - 97
  • [40] 2021 Spanish Society of Hypertension position statement about telemedicine
    Gijon-Conde, T.
    Rubio, E.
    Gorostidi, M.
    Vinyoles, E.
    Armario, P.
    Rodilla, E.
    Segura, J.
    Divison-Garrote, J. A.
    Garcia-Donaire, J. A.
    Molinero, A.
    Ruilope, L. M.
    HIPERTENSION Y RIESGO VASCULAR, 2021, 38 (04): : 186 - 196
12345